Celiac Disease Profile Test in Lahore at Lahore PCR Lab

Celiac Disease Profile at Lahore PCR Lab

The Celiac Disease Profile at Lahore PCR Lab is a comprehensive, state-of-the-art panel of serological blood tests designed to screen for, diagnose, and monitor gluten-sensitive enteropathy, commonly known as celiac disease. Celiac disease is a serious, systemic autoimmune disorder triggered by the ingestion of gluten—a protein composite found in wheat, barley, and rye—in genetically predisposed individuals. When a person with celiac disease consumes gluten, their immune system mounts an abnormal response that targets and damages the mucosal lining of the small intestine, specifically the microscopic, finger-like projections called villi. These villi are responsible for absorbing essential nutrients from food. Over time, persistent inflammation leads to villous atrophy, severely compromising nutrient absorption and leading to chronic malnutrition, systemic complications, and a wide array of gastrointestinal and extraintestinal symptoms.

To evaluate this complex immunological response, the Celiac Disease Profile at Lahore PCR Lab utilizes advanced laboratory technologies, such as Enzyme-Linked Immunosorbent Assay (ELISA) or Chemiluminescent Immunoassay (CLIA). These highly sensitive methodologies detect and quantify specific autoantibodies circulating in the patient's blood. The comprehensive profile typically measures key immunoglobulins, including Tissue Transglutaminase IgA and IgG (tTG-IgA/IgG), Deamidated Gliadin Peptide IgA and IgG (DGP-IgA/IgG), and Total Serum Immunoglobulin A (IgA). Evaluating these specific markers provides clinicians with a detailed immunological map, allowing for an accurate assessment of the patient's autoimmune status. This diagnostic value is paramount; it helps distinguish celiac disease from other gastrointestinal disorders with overlapping symptoms, such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), or non-celiac gluten sensitivity, thereby guiding the clinical team toward the most effective therapeutic pathway.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is absolutely critical to ensure the clinical accuracy and diagnostic validity of the Celiac Disease Profile. Patients must adhere strictly to the following pre-test guidelines:

• Maintain a Gluten-Containing Diet: The most vital preparation requirement is that the patient must continue to consume a normal, gluten-containing diet for at least 6 to 8 weeks prior to the blood draw. This typically involves eating gluten in at least one meal daily (equivalent to about two slices of wheat bread per day). If a patient has already initiated a gluten-free diet (GFD) before testing, circulating antibody levels will rapidly decline, which can lead to false-negative results, masking the underlying disease and delaying accurate diagnosis.
• Do Not Self-Diagnose or Modify Diet: Patients should never eliminate gluten from their diet before consulting their physician or undergoing this profile, even if they suspect gluten is the cause of their symptoms.
• Fasting Requirements: Routine fasting is generally not mandatory for a Celiac Disease Profile. However, patients are advised to consult with Lahore PCR Lab or their referring physician, as concurrent tests ordered alongside this profile might require fasting.
• Hydration: Adequate hydration is highly recommended. Drinking plenty of water before the procedure makes the veins more accessible, facilitating a smoother and quicker blood draw.
• Medication Disclosure: Patients must inform the healthcare team of all medications, immunosuppressants, or corticosteroids they are currently taking, as these substances can suppress the immune response and alter antibody levels.

During the Procedure

The Celiac Disease Profile is a straightforward, minimally invasive laboratory investigation performed via a standard venipuncture (blood draw). The entire procedure is conducted under strict aseptic conditions by highly trained phlebotomists at Lahore PCR Lab:

• Patient Positioning: The patient is comfortably seated in a specialized blood collection chair, and the phlebotomist assesses the arm to locate a suitable, prominent vein, typically in the antecubital fossa (the bend of the elbow).
• Aseptic Preparation: Once the vein is selected, the phlebotomist applies a tourniquet a few inches above the site to increase venous pressure and make the vein more visible. The skin is then thoroughly cleansed with an antiseptic swab (usually 70% isopropyl alcohol) and allowed to air dry to prevent contamination of the sample.
• Sample Collection: Using a sterile, single-use needle attached to a vacuum collection tube (typically a serum separator tube or SST), the phlebotomist gently inserts the needle into the vein. The required volume of blood is drawn into the tube. The patient may feel a brief, minor pinch or stinging sensation as the needle enters the skin.
• Post-Collection Care: Once the blood collection is complete, the tourniquet is released, the needle is carefully withdrawn, and immediate, gentle pressure is applied to the puncture site with a sterile gauze pad or cotton ball to promote hemostasis. A small adhesive bandage is then applied over the site.
• Duration and Safety: The entire phlebotomy process takes less than five minutes. It is exceptionally safe, with minimal risks that are limited to minor, localized bruising or temporary soreness at the needle insertion site.

When is a Celiac Disease Profile Performed?

Investigation of Chronic Gastrointestinal Symptoms

Physicians frequently request a Celiac Disease Profile when a patient presents with persistent, unexplained gastrointestinal distress. Symptoms such as chronic or intermittent diarrhea, abdominal pain, cramping, bloating, excessive flatulence, and unexplained weight loss are classic indicators of potential enteropathy. By measuring specific autoantibodies, the profile helps determine whether these symptoms are driven by an autoimmune reaction to gluten, allowing clinicians to differentiate celiac disease from functional bowel disorders like irritable bowel syndrome (IBS).

Evaluation of Unexplained Nutritional Deficiencies

Because celiac disease damages the absorptive surface of the small intestine, it often manifests first as unexplained nutritional deficiencies. A primary clinical indication for this test is refractory iron-deficiency anemia that does not respond to oral iron supplementation. Other deficiencies, such as low levels of Vitamin D, calcium, folate, or Vitamin B12, can also signal malabsorption. The Celiac Disease Profile assists in identifying whether underlying mucosal damage from gluten exposure is the root cause of these systemic nutritional deficits.

Screening High-Risk Pediatric Patients

In infants and children, celiac disease can severely impact growth and development. Pediatricians order this profile when a child exhibits failure to thrive, delayed puberty, short stature, chronic vomiting, or persistent abdominal distension. Early detection through serological screening is vital to prevent permanent developmental delays, bone density issues, and dental enamel defects, ensuring that the child can transition to a gluten-free diet and resume normal growth trajectories.

Screening Individuals with Associated Autoimmune Disorders

Celiac disease shares a strong genetic link with other autoimmune conditions. Clinical guidelines recommend screening individuals who have been diagnosed with Type 1 Diabetes Mellitus, autoimmune thyroiditis (such as Hashimoto's thyroiditis), Graves' disease, Sjögren's syndrome, or selective IgA deficiency. Additionally, because celiac disease is highly hereditary, first-degree relatives (parents, siblings, children) of confirmed celiac patients are routinely screened using this profile, even if they are currently asymptomatic.

Monitoring Adherence and Response to a Gluten-Free Diet

For patients with a established diagnosis of celiac disease, the profile is performed periodically to monitor the effectiveness of dietary management. After transitioning to a strict gluten-free diet, the levels of circulating autoantibodies should gradually decline and eventually normalize. Persistent or rising antibody levels during follow-up testing indicate ongoing gluten exposure, which may be due to accidental dietary cross-contamination, hidden gluten in processed foods, or, in rare cases, refractory celiac disease.

What Does a Celiac Disease Profile Detect?

The Celiac Disease Profile detects a specific spectrum of immunological markers and clinical findings that indicate the body's response to gluten. The key findings and parameters detected by this profile include:

• Tissue Transglutaminase (tTG) IgA Antibodies: The primary and most sensitive screening marker for celiac disease in individuals who are not IgA deficient.
• Tissue Transglutaminase (tTG) IgG Antibodies: An essential marker used to detect celiac disease in patients who have an underlying selective IgA deficiency.
• Deamidated Gliadin Peptide (DGP) IgA Antibodies: Highly specific antibodies directed against modified gluten proteins, particularly useful in young children.
• Deamidated Gliadin Peptide (DGP) IgG Antibodies: A highly reliable indicator of celiac disease, especially valuable when paired with tTG-IgG in IgA-deficient individuals.
• Endomysial Antibody (EMA) IgA: A highly specific autoantibody directed against the connective tissue surrounding smooth muscle fibers, used to confirm positive tTG results.
• Total Serum Immunoglobulin A (IgA) Levels: Measured to rule out selective IgA deficiency, a condition that occurs in 2-3% of celiac patients and can cause false-negative IgA antibody results.
• Active Autoimmune Enteropathy: Elevated levels of tTG-IgA and EMA-IgA strongly point to active, gluten-induced damage to the small intestinal mucosa.
• Selective IgA Deficiency: Detected when total serum IgA is extremely low or undetectable, prompting the clinical laboratory to rely on IgG-based markers (tTG-IgG and DGP-IgG) for diagnosis.
• Dietary Compliance: Normal or significantly decreased antibody levels in a patient previously diagnosed with celiac disease, indicating successful adherence to a gluten-free diet.
• Accidental Gluten Exposure: Mildly elevated or fluctuating antibody levels in patients on a gluten-free diet, suggesting hidden gluten consumption.
• Refractory Celiac Disease: Persistently high antibody levels despite a documented, strictly managed gluten-free diet, indicating a rare, non-responsive form of the disease.
• High Probability of Villous Atrophy: Strongly elevated tTG-IgA levels (often greater than 10 times the upper limit of normal) correlate highly with severe duodenal villous atrophy.
• Indication for Duodenal Biopsy: Positive serological findings that establish the clinical necessity for an upper endoscopy and confirmatory tissue biopsy.
• Seronegative Celiac Disease: A clinical scenario where a patient has characteristic symptoms and biopsy-proven celiac disease but displays normal antibody levels (found in a small percentage of patients).
• Gluten-Sensitive Dermatitis Herpetiformis: Specific antibody profiles that support the diagnosis of this blistering skin manifestation of celiac disease.
• Pediatric Celiac Disease Indicators: Elevated DGP antibodies in children under the age of two, who may not produce robust tTG-IgA responses.
• Autoimmune Cross-Reactivity: Patterns of antibody elevation that may suggest co-existing autoimmune conditions.
• Epithelial Cell Damage: Indirect evidence of ongoing damage to the enterocytes of the small intestine.
• Malabsorption Risk: Identification of patients at high risk for metabolic bone disease or severe nutritional deficiencies based on antibody severity.
• Genetic Predisposition Correlation: Serological evidence that aligns with genetic susceptibility markers (HLA-DQ2/DQ8) to confirm or rule out the disease.

Turnaround Time and Report Access at Lahore PCR Lab

At Lahore PCR Lab, we understand that waiting for diagnostic results can be an anxious time for patients and their families. The Celiac Disease Profile involves highly specialized, multi-parameter immunological testing that requires meticulous processing and quality control. Typically, the completed, verified report is ready within 24 to 48 hours from the time of sample collection. This rapid turnaround time ensures that your healthcare provider can promptly review the findings and initiate an appropriate management plan without unnecessary delay.

Lahore PCR Lab offers convenient, modern digital access to your diagnostic reports. Once our consultant pathologists have reviewed and authorized your results, you will receive an automated SMS notification containing a secure, direct link to download your report in PDF format. Additionally, patients can access their complete diagnostic history online through the official Lahore PCR Lab web portal. For those who prefer physical copies, printed reports can be collected directly from our main diagnostic facility in Lahore or any of our designated collection centers.

Celiac Disease Profile Findings Overview

The following table outlines the key parameters evaluated in the Celiac Disease Profile, along with their clinical significance, normal reference ranges, and possible abnormal findings:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Tissue Transglutaminase (tTG) IgA	Negative (typically < 10 U/mL)	Positive (≥ 10 U/mL); indicates active autoimmune response to gluten in individuals with normal IgA levels.
Tissue Transglutaminase (tTG) IgG	Negative (typically < 10 U/mL)	Positive (≥ 10 U/mL); highly indicative of celiac disease, especially in patients with selective IgA deficiency.
Deamidated Gliadin Peptide (DGP) IgA	Negative (typically < 20 U/mL)	Positive (≥ 20 U/mL); indicates immune reaction to modified gluten; highly sensitive in young children.
Deamidated Gliadin Peptide (DGP) IgG	Negative (typically < 20 U/mL)	Positive (≥ 20 U/mL); useful for diagnosing celiac disease, particularly in IgA-deficient individuals.
Endomysial Antibody (EMA) IgA	Negative / Not Detected	Positive / Detected; highly specific confirmatory marker for gluten-sensitive enteropathy.
Total Serum Immunoglobulin A (IgA)	Normal for age (e.g., 70–400 mg/dL)	Low or Undetectable (< 70 mg/dL); indicates selective IgA deficiency, which can cause false-negative IgA results.
Overall Profile Interpretation	All antibody markers negative; normal total IgA	Multiple positive antibodies; suggests high probability of celiac disease requiring duodenal biopsy confirmation.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient's symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for Celiac Disease Profile?

• Experienced healthcare professionals: Our clinical team consists of highly qualified pathologists, immunologists, and laboratory technologists dedicated to diagnostic excellence.
• Patient-focused care: We prioritize patient comfort, safety, and clear communication throughout the entire testing process.
• Quality diagnostic services: Lahore PCR Lab adheres to stringent international quality control standards, ensuring the highest level of accuracy for all serological assays.
• Professional reporting: Our reports are comprehensive, easy to understand, and verified by senior consultant pathologists to assist your physician in making precise clinical decisions.
• Modern diagnostic approach: We utilize advanced automated immunoassay platforms (ELISA/CLIA) to deliver highly sensitive and reproducible results.
• Comfortable environment: Our state-of-the-art sampling facilities in Lahore are designed to provide a stress-free, hygienic, and comfortable experience for patients of all ages.
• Convenient location: Situated in a highly accessible area of Lahore, our main lab and collection centers are easy to reach for routine and specialized testing.
• Commitment to accurate diagnosis: We are dedicated to providing precise, evidence-based diagnostic insights that form the foundation of effective medical treatment.